Cargando…
Ligustrazine Inhibits Lung Phosphodiesterase Activity in a Rat Model of Allergic Asthma
OBJECTIVES: This study sought to examine whether ligustrazine was capable of inhibiting phosphodiesterase (PDE) activity and improving lung function in a rat model of asthma. METHODS: Rats were initially sensitized using ovalbumin (OVA) and then were challenged daily with aerosolized OVA beginning 1...
Autores principales: | Wang, Yajuan, Zhu, Huizhi, Tong, Jiabing, Li, Zegeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8763486/ https://www.ncbi.nlm.nih.gov/pubmed/35047052 http://dx.doi.org/10.1155/2022/1452116 |
Ejemplares similares
-
Pharmacokinetic study on the effect of ligustrazine–tangeretin co‐administration on the pharmacokinetics of ligustrazine and its potential mechanism in rats
por: Liu, Dandan, et al.
Publicado: (2023) -
Inhibition of phosphodiesterase suppresses allergic lung inflammation by regulating MCP-1 in an OVA-induced asthma murine model with co-exposure to lipopolysaccharide
por: Lee, Chang Doo, et al.
Publicado: (2020) -
The effect of selective phosphodiesterase inhibitors, alone and in combination, on a murine model of allergic asthma
por: Clayton, Robert A, et al.
Publicado: (2004) -
Ligustrazine Inhibits the Migration and Invasion of Renal Cell Carcinoma
por: Zhang, Xufeng, et al.
Publicado: (2023) -
Effect of Ligustrazine on Endometrium Injury of Thin Endometrium Rats
por: Ye, Qing, et al.
Publicado: (2019)